Copenhagen Life Science Advisors

connecting science to market

We are a dedicated life sciences consultancy company with years of experience from the pharmaceutical, biotech and medtech industries, as well as experience from working in and with life science venture capital.

We work closely with our clients to secure a detailed understanding of the specific challenges at hand in order to provide actionable solutions.

In addition to our native network in Denmark, we have a strong network across the life sciences industry and venture firms in Europe and the US.

Jarne Elleholm

Jarne Elleholm, founder and Managing Partner, has more than 20 years’ experience in the life science industry with strong record of achievements in commercialization of drugs and medtech products, as well as in fundraising for early stage life science companies.

Prior to establishing Copenhagen Life Science Advisors, he worked in the venture capital industry as partner in Vækstfonden and as Managing Partner in Inventure Capital. During this period he worked closely with 12 life science portfolio companies as active lead investor and board member or chairman.

From 2005-07 he served as CEO of biotech company Aresa A/S, where he built up the organization and completed an IPO raising more than DKK 50 million.

Prior experience includes European Vice President for Whatman International (now part of GE Healthcare) and CEO for Lundbeck Ltd. UK where he successfully launched several pharmaceutical products.

Jarne Elleholm currently services as Chairman of the Board of Alcowhey. Prior positions include Chairman of Scandinavian Micro Biodevices SMB, Meta-IQ, Fluxome Sciences, FCMB, RSP Systems and Medotech, and board member of CytoVac, Action Pharma, Quantibact, Proxeon and Liplasome Pharma.

Jarne holds two B.Com degrees from Copenhagen Business School and an MBA from INSEAD.

Torben Skarsfeldt

Torben Skarsfeldt, Managing Director, has more than 30 years experience in the life science industry with a strong record of achievements in research and development.

Prior to joining Copenhagen Life Science Advisors he worked within research, business development and project management at H. Lundbeck A/S handling both small molecules as well as biological products. Furthermore, as a consultant he has orchestrated successful regulatory pathways from preclinical into IND in the US.

Torben Skarsfeldt I currently CEO and owner of Pharma Guidance ApS, and serves as Scandinavian Advisor for the Ferghana Partners Group. He is member of the KLIFO Drug Development Counsel and a Board member of ArrayDignostics. He previously served 16 years as member of the Supervisor Board of H. Lundbeck A/S in Denmark.

Torben holds a M.Sc. a D.Sc from Copenhagen University.

Morten Faester

Senior Partner with special focus on Business Development.

Morten has 20 years’ experience in the international biopharma industry with a strong track-record of partnering and deal-making.

Prior to joining Copenhagen Life Science Advisors he worked with big-pharma and speciality-pharma companies.

From 2002-09 he was Senior Director with Nyucomed-Takeda, followed by a 3 year term as Lifescienc Ambassador in Canada for the Bio Industry Association. Subsequently Morten wored as a Business Development executive with AstraZeneca in Sweden, and most recently in a senior role within Corporate Development for Grünenthal in Germany.

Morten Faester currently serves as a mentor and strategic advisor to several Scandinavian biotech, medtech and diagnostic companies.

Morten has a commercial education as BBA from Copenhagen Business School and holds an MBA from Heriot-Watts University in Edinburgh Scotland.